Company
Shanghai Henlius Biotech
Shanghai Henlius Biotech has 1 drug tracked on RxWires: 1 in Phase 2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Serplulimab + chemotherapy (carboplatin-etoposide) | Phase 2 | Extensive Stage Small Cell Lung Cancer |
Latest
No recent events.
Follow Shanghai Henlius Biotech on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.